ISG15 expression exhibits heterogeneity in tumors; in addition to a small number of cancers, ISG15 expression is obviously upregulated in a large number of tumors, such as bladder cancer, breast cancer, and ovarian cancer (Figure 3A). Here, ISG15 is linked to cancer.